Prognostic Value of Redox Status Biomarkers in Patients Presenting with STEMI or Non-STEMI: A Prospective Case-Control Clinical Study

Figures

• 

  Figure 1. Plasma concentration of superoxide anion radicals among STEMI, non-STEMI, and healthy participants measured at admission (T0), 6 h after admission (T6), and 12 h after admission (T12). Results are presented as mean ± standard deviation (X ± SD).

• 

  Figure 2. Plasma concentration of hydrogen peroxide among STEMI, non-STEMI, and healthy participants measured at admission (T0), 6 h after admission (T6), and 12 h after admission (T12). Results are presented as mean ± standard deviation (X±SD).

• 

  Figure 3. Plasma concentration of nitric oxide measured as nitrites among STEMI, non-STEMI, and healthy participants measured at admission (T0), 6 h after admission (T6), and 12 h after admission (T12). Results are presented as mean ± standard deviation (X ± SD).

• 

  Figure 4. Plasma concentration of index of lipid peroxidation measured as TBARS among STEMI, non-STEMI, and healthy participants measured at admission (T0), 6 h after admission (T6), and 12 h after admission (T12). Results are presented as mean ± standard deviation (X ± SD).

• 

  Figure 5. Catalase activity in hemolysate of STEMI, non-STEMI, and healthy participants measured at admission (T0), 6 h after admission (T6), and 12 h after admission (T12). Results are presented as mean ± standard deviation (X ± SD).

• 

  Figure 6. Reduced glutathione content in hemolysate of STEMI, non-STEMI, and healthy participants measured at admission (T0), 6 h after admission (T6), and 12 h after admission (T12). Results are presented as mean ± standard deviation (X ± SD).

• 

  Figure 7. Superoxide dismutase activity in hemolysate of STEMI, non-STEMI, and healthy participants measured at admission (T0), 6 h after admission (T6), and 12 h after admission (T12). Results are presented as mean ± standard deviation (X ± SD).

• 

  Figure 8. ROC curve of significant variables O2− and hsTPI of STEMI, non-STEMI, and healthy participants.

• 

  Figure 9. ROC curve of significant variables GSH and NT-pBNP of STEMI, non-STEMI, and healthy participants.